339
Views
23
CrossRef citations to date
0
Altmetric
Original Article

Clinical assessment of the effect of a matrix metalloproteinase inhibitor on aphthous ulcers

, &
Pages 25-29 | Received 27 Jun 2008, Published online: 02 Jul 2009

References

  • Jurge S, Kuffer R, Scully C, Porter SR. Recurrent aphthous stomatitis. Oral Diseases 2006; 12: 1–21
  • Marchini L, Campos MS, Silva AM, Paulino LC, Nobrega FG. Bacterial diversity in aphthous ulcers. Oral Microbiol Immunol 2007; 22: 225–31
  • Axell T, Henricsson V. The occurrence of recurrent aphthous ulcers in an adult Swedish population. Scand J Dent Res 1985; 93: 239–42
  • Wray D, Ferguson MM, Mason DK, Hutcheon AW, Dagg JH. Recurrent aphthae: treatment with vitamin B12, folic acid, and iron. Br Med J 1975; 2: 490–3
  • Baert JH, Veys RJ, Ampe K, De Boever JA. The effect of sodium lauryl sulphate and triclosan on hamster cheek pouch mucosa. Int J of Exp Path 1996; 77: 73–8
  • Herlofson BB, Brodin P, Aars H. Increased human gingival blood flow induced by sodium lauryl sulphate. J Clin Periodontol 1996; 23: 1004–7
  • Lehner T, Lavrey E, Smith R, van der Zee R, Mizushima Y, Shinnick T. Association between the 65-kilodalton heat shock protein, Streptococcus sanguis, and the corresponding antibodies in Bechcet's syndrome. Infect Immun 1991; 59: 1434–41
  • Prego V, Aytaman A, Levendoglu H, Fruchter G. Intralesional steroids are a safe and effective therapy in HIV-related aphthous ulcerations of the esophagus. Gastroenterology 1993; 104: A764
  • Hayrinen-Immonen R, Sorsa T, Nordström D, Malmström M. Collagenase and stromelysin in recurrent aphthous ulcers (RAU). Int J Oral Maxillofac Surg 1993; 22: 46–9
  • Hayrinen-Immonen R, Sorsa T, Pettila J, Konttinen YT, Teronen O, Malmström M. Effect of tetracyclines on collagenase activity in patients with recurrent aphthous ulcers. J Oral Path Med 1994; 23: 269–72
  • Alpagot T, Suzara V, Bhattacharyya M. The associations between gingival crevice fluid matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 and periodontitis in human immunodeficiency virus-positive patients. J Periodont Res 2006; 41: 491–7
  • Mackay AR, Corbitt RH, Hartzler JL, Thorgeirsson UP. Basement-membrane type-IV collagen degradation – evidence for the involvement of a proteolytic cascade independent of metalloproteinases. Cancer Res 1990; 50: 5997–6001
  • Birkedal-Hansen H. Role of matrix metalloproteinases in human periodontal diseases. J Periodontol 1993; 64: 474–84
  • Golub LM, Ramamurthy NS, McNamara TF, Greenwald RA, Rifkin BR. Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs. Crit Rev Oral Biol Med 1992; 2: 297–321
  • Ciancio S, Ashley R. Safety and efficacy of sub-antimicrobial-dose doxycycline therapy in patients with adult periodontitis. Adv Dent Res 1998; 12: 27–31
  • British National Formulary. Drugs for oral ulceration and inflammation. London: British Medical Association/Royal Pharmaceutical Society of Great Britain. BNF no. 42. 2001;522–3.
  • British National Formulary. 12.3.1. Drugs for oral ulceration and inflammation. London: British Medical Association/Royal Pharmaceutical Society of Great Britain. BNF no. 52. 2006.
  • Burns FR., Stack MS, Gray RD, Paterson CA. Inhibition of purified collagenase from alkali-burned rabbit corneas. Invest Ophthalmol Vis Sci 1989; 30: 1569–75
  • Paemen L, Martens E, Norga K, Masure S, Roets E, Hoogmartens J, et al. The gelatinase inhibitory activity of tetracyclines and chemically modified tetracycline analogues as measured by a novel microtiter assay for inhibitors. Biochem Pharmacol 1996; 52: 105–11
  • Golub LM, Lee HM, Lehrer G, Nemiroff A, McNamara TF, Kaplan R, et al. Minocycline reduces gingival collagenolytic activity during diabetes: preliminary observations and a proposed new mechanism of action. J Periodont Res 1983; 18: 516–26
  • Ryan ME, Ashley A. How do tetracyclines work?. Adv Dent Res 1998; 12: 149–51
  • Thomas J, Crout RJ, Crout RM, Cook D, Keating J, Casto G, et al. Antibiotic resistance evaluation with low-dose doxycycline (LDD) in adult periodontitis. J Dent Res 1995; 74: 575 (1394)
  • Schroeder K, Ramamurthy NS, Szczepanek KA, Tofil P, Smith R, Lee HM, et al. Low-dose doxycycline (LDD) prevents attachment loss in adult periodontitis. J Dent Res 1992; 71: 758 (1936)
  • Greenstein G. Efficacy of subantimicrobial-dose doxycycline in the treatment of periodontal diseases: a critical evaluation. Int J Periodont Restorative Dent 2004; 24: 528–43
  • Bonito AJ, Luc L, Lohr KN. Impact of local adjuncts to scaling and root planing in periodontal disease therapy: a systematic review. J Periodontol 2005; 76: 1227–36
  • Henricsson V, Axéll T. Treatment of recurrent aphthous ulcers with Aureomycin® mouth rinse or Zendium® dentifrice. Acta Odontol Scand 1985; 43: 47–52
  • Liu J, Xiong W, Baca-Regen L, Nagase H, Baxter BT. Mechanism of inhibition of matrix metalloproteinase-2 expression by doxycycline in human aortic smooth muscle cells. J Vasc Surg 2003; 38: 1376–83

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.